Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avricore Health Inc V.AVCR

Alternate Symbol(s):  AVCRF

Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). The HealthTab also has capabilities for bacterial and viral tests, such as strep and COVID-19. The HealthTab platform transforms pharmacies into community point-of-care diagnostic centers.


TSXV:AVCR - Post by User

Bullboard Posts
Post by kingposton Dec 21, 2015 2:39pm
299 Views
Post# 24402145

"build a large product portfolio......both Generic and OTC"

"build a large product portfolio......both Generic and OTC"The quote from  Arun below (and posted by SW)  I think holds PART of the answer to where NPH is going...

Arun
"We can source from various vendors as long as these organizations are approved from health Canada. This helps us to build a large product portfolio.  Our competitors are mostly focused on Generics alone or OTC products alone. We see ourselves working towards both a Generic and OTC products company."

I am expecting rapid growth of this portfolia; but also as I said, adding in some very lucrative brand products as well., that from a bottom line profit stand point could have meaningfull large upside (this will be the cream that comes with the business model) ....I would not be surprised if the combined generic and OTC portfolio doubles again in the next 18 monthes, and I am basing this on expanding their existing relationships primarily.....and the clues that lead me to think this  are there now ..JMHO...






Bullboard Posts